Nissui Q1 FY2027: Record Sales, Operating Profit Up 21%
Revenue
¥257.2B
+14.1%
Full-year forecast
¥1.0T
Operating Profit
¥12.4B
+20.9%
Full-year forecast
¥42.5B
Net Income
¥7.4B
+14.3%
Full-year forecast
¥29.0B
Operating Margin
4.8%
Nissui reported record Q1 revenue of ¥257.2 billion, up 14.1%, boosted by a weak yen and strong marine and fine-chemical demand. Operating profit rose 20.9% to ¥12.4 billion, and net income gained 14.3% to ¥7.4 billion.
Key Results
Nissui’s first-quarter revenue rose 14.1% year on year to **¥257.2 billion**, a record for the April-June period. Operating profit climbed 20.9% to ¥12.4 billion, while net income attributable to shareholders increased 14.3% to ¥7.4 billion.
The growth was fueled by strong performance in the Marine and Fine Chemicals businesses, which offset a profit decline in the Food segment. A weaker yen, with the dollar averaging ¥156.45 against ¥151.21 a year earlier, provided an estimated ¥9.8 billion boost to revenue.
Total assets expanded by ¥33.1 billion from the prior fiscal year-end to ¥782.6 billion, driven by capital investments and higher working capital. Interest-bearing debt rose, pushing the net debt-to-equity ratio to 0.9, above the company’s target range of 0.7–0.8. Free cash flow was deeply negative, but the company prioritized growth investment.
Segment Performance
The Marine Business posted revenue of ¥107.6 billion (up 24.6%) and operating profit of ¥5.4 billion (up 72.6%), driven by higher domestic catches of horse mackerel, rising selling prices for sardines and mackerel, and stronger sales volumes and prices for cod, crab, and salmon/trout in North America. The segment also benefited from buoyant domestic sales of yellowtail and fish oil/meal.
The Food Business revenue rose 7.4% to ¥138.2 billion, but operating profit slipped 4.1% to ¥8.4 billion. Higher surimi raw material costs and a pullback in convenience-store demand following the previous year’s special surge outweighed price revisions, particularly hurting the chilled-food unit.
The Fine Chemicals Business revenue climbed 24.4% to ¥3.8 billion, and operating profit swung to ¥0.5 billion from roughly zero a year earlier, supported by robust shipments of pharmaceutical ingredients and functional materials for supplements, along with improved capacity utilization.
The Logistics Business revenue edged up 3.4% to ¥4.2 billion, but operating profit fell 6.9% to ¥0.5 billion due to rising labor costs.
Other revenue rose 3.6% to ¥3.3 billion, with operating profit of ¥0.1 billion.
| Segment | Revenue | Share | Op. Profit | Op. Margin |
|---|---|---|---|---|
| Marine Business | ¥107.6B | 42% | ¥5.4B | 5.0% |
| Food Business | ¥138.2B | 54% | ¥8.4B | 6.1% |
| Fine Chemicals Business | ¥3.8B | 2% | ¥500M | 13.2% |
| Logistics Business | ¥4.2B | 2% | ¥500M | 11.9% |
| Other | ¥3.3B | 1% | ¥100M | 3.0% |
Financial Position and Capital Policy
Total assets at the end of the quarter stood at ¥782.6 billion, up ¥33.1 billion from the fiscal year-end, while the equity ratio dipped 1.0 percentage point to 39.1%. The net debt-to-equity ratio rose to 0.9, exceeding the target range of 0.7–0.8, as strategic acquisitions and capacity expansions pushed up interest-bearing debt.
Operating cash flow turned negative at -¥5.3 billion (vs. +¥2.8 billion a year earlier) as higher receivables from North American food sales and repayment of long-term payables related to the South American aquaculture acquisition consumed ¥11.1 billion in working capital. Investing cash flow was -¥13.3 billion due to increased capex (¥14.5 billion vs. ¥9.1 billion). Free cash flow was -¥18.6 billion, but the company raised ¥28.8 billion via short-term borrowings and commercial paper, securing liquidity.
No dividend increase or share buyback was announced, signalling a near-term focus on growth investment. The outlook for cash flow improvement hinges on a turnaround at the South American salmonid operation and tight working-capital control.
Full-Year Outlook
Nissui raised its full-year revenue forecast by 2.0% to ¥1,000.0 billion (previously ¥980.0 billion), while keeping operating profit at ¥42.5 billion, ordinary profit at ¥43.0 billion, and net profit at ¥29.0 billion unchanged. The upgrade reflects a revised yen assumption of ¥155 per dollar (from ¥150) and stronger marine sales, though headwinds such as Middle East instability, raw material inflation, and a slower recovery in South American aquaculture continue to weigh on margins.
Revised segment forecasts are as follows (in billions of yen):
| Segment | Revised Revenue | Revised Op. Profit | Revenue Change | Op. Profit Change |
|---|---|---|---|---|
| Marine Business | ¥422.4 | ¥21.9 | +¥15.0 | +¥0.3 |
| Food Business | ¥525.6 | ¥27.5 | +¥5.0 | -¥0.3 |
| Fine Chemicals | ¥17.4 | ¥1.8 | 0 | 0 |
| Logistics | ¥17.7 | ¥2.6 | 0 | 0 |
| Other | ¥16.9 | ¥0.1 | 0 | 0 |
Management acknowledged the South American aquaculture business is off its plan due to disease and survival rate issues, but expects corrective actions to drive a return to profitability by the fourth quarter. Feed cost increases are a second-half concern, though domestic aquaculture productivity gains and smart-factory efficiencies are expected to provide some buffer.
Risks and Challenges
- Geopolitical risk: Middle East instability could disrupt shipping routes and logistics costs, affecting seafood supply and demand.
- Raw material price surge: Higher surimi and feed costs may squeeze margins in the food and aquaculture segments if price hikes are delayed.
- Currency volatility: A stronger yen than the assumed ¥155 per dollar would erode export profitability and overseas earnings.
